All Recalls

92,900 total recalls in our database

Our supplier, GKI, did not have milk declared as an allergen on an item we repackage. Therefore our labels did not contain milk

Nov 1, 2017 Snacks & Candy Nationwide View Details β†’

Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets

Nov 20, 2017 Prescription Drugs Nationwide View Details β†’

CGMP Deviations: products manufactured in a manner that may impact product quality that includes but is not limited to failed viscosity.

Nov 28, 2017 Other Drugs Nationwide View Details β†’

There is a possibility that the finished good kits may contain 5 Fr peel-away sheaths instead of the required 4 Fr peel-away sheaths.

Jun 1, 2017 Diagnostic Equipment Nationwide View Details β†’

There is a possibility that the finished good kits may contain 5 Fr peel-away sheaths instead of the required 4 Fr peel-away sheaths.

Jun 1, 2017 Diagnostic Equipment Nationwide View Details β†’

Monarch Electromagnetic Interference (EMI) may disrupt the operation of implanted pacemakers or implantable cardioverter defibrillators as well as other devices that might be subject to an EMI if they come into direct contact with the Monarch device.

Sep 15, 2017 Other Medical Devices Nationwide View Details β†’

Brainlab has internally detected that under specific conditions ExacTrac Vero may not correctly account for this ring angle correction during the calculation of the corresponding couch shift. This may result in the treatment couch not moving to the exact planned position resulting in a deviation between the planned and the treatment target position. This deviation may not be clearly visible to the user if no verification image of the patient position is acquired after this couch shift has been performed.

Nov 3, 2017 Diagnostic Equipment View Details β†’

BD has recently confirmed quality control failures, related to a manufacturing issue, for the inducible macrolide-linosamide-streptogramin B (iMLSb) test contained on lot 7031818 of Phoenix panels. The iMLSb resistance D-test screen for Staphylococcus species is used to identify phenotypic drug resistance to clindamycin and erythromycin. As the product should not be used when quality control (QC) fails, it is unlikely that there would be any impact on patient results, however, if a customer does not perform QC testing and uses the panel, there is a potential to incorrectly treat a Staphylococcus infection with clindamycin based on the iMLSb test result. This issue can be detected 100% of the time when used per package insert instructions with iMLSb positive strain S. aureus BAA-977.

May 11, 2017 Diagnostic Equipment View Details β†’
πŸ₯ Medical Devices Class I - Dangerous

Issue with optional neuro-endoscopy module detected under specific conditions during internal testing.

Feb 10, 2013 Surgical Instruments View Details β†’